Foot Drop Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Foot Drop Treatment Devices Market By Product Type (Electrical Stimulator, Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of various knee-associated musculoskeletal disorders, and rising prevalence of neuromuscular diseases among others
The foot drop treatment devices market is estimated to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030. The foot drop treatment devices market is witnessing positive growth owing to the rising prevalence of various knee-associated musculoskeletal disorders, the rising prevalence of neuromuscular diseases, and the increasing geriatric population among other key factors, contributing to the growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.

Foot Drop Treatment Devices Market Dynamics:

According to the World Health Organization (WHO) report 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Moreover, according to the same report, musculoskeletal conditions are the leading contributor to disability worldwide.

So, the rising prevalence of knee-associated musculoskeletal disorders can serve as a contributing factor to the foot drop treatment market by highlighting the interconnectedness of lower limb pathologies and the need for holistic approaches to address functional impairments. This underscores the importance of multidisciplinary care and tailored interventions to effectively manage foot drop in individuals with knee-related conditions. Hence it will create a significant opportunity for the foot drop treatment devices market.
Moreover, according to the United Nations World Population Ageing 2022 highlights, the percentage of the global population aged 65 and above is expected to rise from 10% in 2022 to 16% by 2050. It is projected that by 2050, the number of individuals aged 65 years or above across the world will be twice the number of children under age 5 and almost equivalent to the number of children under 12 years.

So, the growing old-age population is more susceptible to suffering from knee-related musculoskeletal disorders such as arthritis which may drive the product demand ultimately driving the market growth.
Furthermore, the integration of Artificial Intelligence (AI) and Robotics in Foot Drop surgical procedures to enhance the efficiency of devices along with procedures has been observed in various research studies, and an increase in R&D expenditure for Foot Drop surgeries is likely to boost the global foot drop treatment devices market.

Furthermore, besides the increase in the geriatric population and integration of Artificial Intelligence, there has been an increase in the number of people living with some form of disability, many of which include complications associated with neuromuscular disorders and need foot drop treatment devices to carry on their day to day activity. According to the factsheet by the World Health Organization (WHO) on Disability, in 2023, over 1.3 billion people experience significant disability. This represents 16% of the world’s population or 1 in 6 of us.
However, side effects associated with prolonged usage and fitting-related issues may be certain limiting factors to the foot drop treatment devices market growth.

Foot Drop Treatment Devices Market Segment Analysis:

Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator, Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the foot drop treatment devices market, electrical stimulators are estimated to hold a significant share in the foot drop treatment devices market in the year 2023. This can be attributed to the specific features associated with these devices.
The electrical stimulation device works by sending impulses to the muscles via surface electrodes that attach to the skin. This causes the muscles to contract and lift the foot. This movement can help build muscle mass, re-engage the brain, and help stretch the back of the calf, which can sometimes become tight.

An added benefit to this is that the user can actively participate in the movement. With this type of stimulation, the patient lifts the ankle as much as possible. The device detects the movement and when the user reaches a preset threshold, the electrical stimulation is triggered to increase the movement further.
Moreover, electric stimulators offer a non-invasive treatment option for foot drop, particularly appealing to patients who may wish to avoid surgery or invasive procedures. Electrical stimulation devices, for example, are typically worn externally and do not require surgical implantation, making them more accessible and widely accepted among patients.

Electric stimulators allow for customization and control over the stimulation parameters, allowing healthcare providers to tailor treatment protocols to each patient's specific needs. This flexibility in programming enables optimal muscle activation and functional improvement, enhancing treatment outcomes.
Therefore, considering their wide advantages, the electrical stimulator category is expected to account for a considerable market share in the Foot Drop Treatment Devices market.

North America Is Expected To Dominate The Overall Foot Drop Treatment Devices Market:

Among all the regions, North America is expected to account for the highest proportion of the foot drop treatment devices market in 2023, out of all the regions. This can be ascribed to the high prevalence of musculoskeletal disorders, the increasing burden of the geriatric population, the highly developed healthcare system, and others act as supportive factors in North American market growth.

On the other hand, stroke is a common cause of foot drop, which makes walking difficult. Foot drop patients struggle with walking because they cannot raise the front part of their foot, typically due to muscle weakness that would normally facilitate this action. According to the Centers for Disease Control and Prevention data published in 2024, every year more than 795,000 people in the United States suffer from a stroke.
Moreover, foot drop is a symptom of multiple sclerosis caused by weakness in the ankle or disruption in the nerve pathway between the legs and the brain. This disruption means it is difficult to lift the front of the foot to the correct angle during walking. Multiple sclerosis is a neurological indication that leads to the weakening of limbs among other range of symptoms. For instance, a recent epidemiological study conducted by the National Multiple Sclerosis Society in the United States estimated that approximately one million people were living with MS in the country (2020).

Moreover, the presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for the foot drop treatment devices market.
Hence, all the above-mentioned factors are likely to contribute to the growth of the foot drop treatment devices market during the forecast period from 2022-2027.

Foot Drop Treatment Devices Market Key Players:

Some of the key market players operating in the foot drop treatment devices market include Bioventus, Ottobock, AxioBionics, Accelerated Care Plus Corporation, Saebo., Boston Orthotics & Prosthetics., Turbomed Orthotics., Össur, OrthoBracing., Allard USA Inc., NextStep Robotics, Finetech Medical, Arthrex, Inc., Evolution Devices, Narang Medical Limited., Hanger Clinic., AliMed, The London Orthotics Consultancy Ltd, Access Prosthetics, Spinal Solutions and others.

Recent Developmental Activities In The Foot Drop Treatment Devices Market:

• In October 2023, Cionic secured an additional $12 million, bringing its total Series A funding to $25 million. The new funding will be used to expand the adoption of the Cionic Neural Sleeve among people affected by mobility impairments. The investment will also support the development of the company’s product pipeline to address a broader spectrum of human mobility issues.
• In November 2022, MyndTec Inc., announced the North American Launch of its Innovative Foot Drop FES Device MyndStep(TM), to its functional electrical stimulation (FES) portfolio.
• In March 2022, Cionic announced FDA clearance for its leg-worn Cionic Neural Sleeve that provides functional electrical stimulation, lightweight Cionic Neural Sleeve to assist in gait for people with foot drop and leg muscle weakness, including those with mobility issues due to multiple sclerosis (MS), stroke, cerebral palsy (CP) and other neurological conditions.

Key Takeaways From The Foot Drop Treatment Devices Market Report Study

• Market size analysis for current Foot Drop Treatment Devices Market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global Foot Drop Treatment Devices market.
• Various opportunities are available for the other competitors in the Foot Drop Treatment Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Foot Drop Treatment Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Foot Drop Treatment Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Foot Drop Treatment Devices Market Report Study

• Foot Drop Treatment Devices product providers
• Research organizations and consulting companies
• Foot Drop Treatment Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Foot Drop Treatment Devices
• Various end-users who want to know more about the Foot Drop Treatment Devices Market and the latest technological developments in the Foot Drop Treatment Devices Market.

Frequently Asked Questions For The Foot Drop Treatment Devices Market:

1. What are Foot Drop Treatment Devices?

Foot drop treatment devices are medical devices designed to address the condition known as foot drop, which is characterized by difficulty in lifting the front part of the foot due to muscle weakness or paralysis. These devices aim to improve mobility, stability, and walking ability in individuals affected by foot drop.

2. What is the market for Foot Drop Treatment Devices?

The foot drop treatment devices market is estimated to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Foot Drop Treatment Devices market?

The foot drop treatment devices market is witnessing positive growth owing to the rising prevalence of various knee-associated musculoskeletal disorders, the rising prevalence of neuromuscular diseases, and the increasing geriatric population among other factors, thereby contributing to the growth of the Foot Drop Treatment Devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global Foot Drop Treatment Devices market?

Some of the key market players operating foot drop treatment devices market include Bioventus, Ottobock, AxioBionics, Accelerated Care Plus Corporation, Saebo., Boston Orthotics & Prosthetics., Turbomed Orthotics., Össur, OrthoBracing., Allard USA Inc., NextStep Robotics, Finetech Medical, Arthrex, Inc., Evolution Devices, Narang Medical Limited., Hanger Clinic., AliMed, The London Orthotics Consultancy Ltd, Access Prosthetics, Spinal Solutions and others.

5. Which region has the highest share in the global Foot Drop Treatment Devices market?

North America is expected to dominate the overall feed testing market during the forecast period from 2024 to 2030. This is due to the region having a high prevalence of musculoskeletal disorders, increasing burden of the geriatric population, highly developed healthcare system, and others acting as supportive factors in North American market growth.


This product will be delivered within 2 business days.